Keyword: Biotechnology

Markets & Companies

Green Chemistry and Smart Chemistry

24.11.2017 - As Austria’s second largest sector, the chemical industry is also among its most important. Spending on chemical research and innovation also surpasses that of other sectors. At...

Markets & Companies

The German Capital Region

24.11.2017 -

The German capital region is one of the leading life sciences and healthcare industries centers in the world. A total of around 30,000 employees work in more than 500...

News

Sanofi, Principia to Develop MS Candidate

16.11.2017 - French drugmaker Sanofi has signed an agreement to develop Principia Biopharma’s experimental oral treatment that is seen to show promise in treating multiple sclerosis (MS) and...

News

Lilly and CureVac in Cancer Vaccines Pact

23.10.2017 - In a deal that could lead to the development of five new cancer vaccines, US drugs giant Eli Lilly is investing in German biopharma CureVac. Lilly will make an equity investment of...

Plant Construction & Process Technology

Both Positive and Negative Effects

02.10.2017 - Does the consolidation in the pharmaceutical industry affect CROs/CMOs, e.g. does it create a necessity for outsourcing partners to consolidate, too? Simon Edwards: It is somewhat...

Plant Construction & Process Technology

Ensuring Better Efficiency and Consistency

28.09.2017 - Does the consolidation in the pharmaceutical industry affect CROs/CMOs, e.g. does it create a necessity for outsourcing partners to consolidate, too? Mark Rogers: Between 1993 and...

Plant Construction & Process Technology

Earning a Large Chunk of the Cake

28.09.2017 - Daniel Mueller: The most obvious effect of consolidation in the pharmaceutical industry is a pronounced shift to those activities within the organization that provide the most...

Plant Construction & Process Technology

Pharma R&D Productivity Needs Improvement

28.09.2017 - Will the consolidation in the pharmaceutical industry level off at any time soon or is it here to stay and will even intensify? Elliott Berger: With the ever-increasing share of...